Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.35 Million CAD | -10.18% |
| 2022 | 3.26 Million CAD | -7.93% |
| 2021 | 3.54 Million CAD | 11.2% |
| 2020 | 3.19 Million CAD | 325.1% |
| 2019 | 750.76 Thousand USD | -6.8% |
| 2018 | 805.53 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 573.47 Thousand CAD | -35.07% |
| 2024 Q1 | 818.02 Thousand CAD | 432.58% |
| 2023 Q2 | 1.01 Million USD | 9.36% |
| 2023 Q1 | 930.14 Thousand CAD | 24.32% |
| 2023 FY | 2.93 Million CAD | -10.18% |
| 2023 Q4 | -245.96 Thousand CAD | -125.97% |
| 2023 Q3 | 947.06 Thousand USD | -6.9% |
| 2022 Q3 | 813.63 Thousand CAD | -0.05% |
| 2022 Q2 | 814.02 Thousand CAD | 12.69% |
| 2022 Q1 | 722.33 Thousand CAD | -9.68% |
| 2022 FY | 3.26 Million CAD | -7.93% |
| 2022 Q4 | 748.18 Thousand CAD | -8.04% |
| 2021 Q2 | 928.12 Thousand CAD | -8.16% |
| 2021 Q3 | 810.59 Thousand CAD | -12.66% |
| 2021 Q4 | 799.72 Thousand CAD | -1.34% |
| 2021 FY | 3.54 Million CAD | 11.2% |
| 2021 Q1 | 1.01 Million CAD | 1884.71% |
| 2020 FY | 3.19 Million CAD | 325.1% |
| 2020 Q4 | 50.91 Thousand CAD | -73.49% |
| 2020 Q3 | 192.08 Thousand CAD | 45.46% |
| 2020 Q2 | 132.05 Thousand CAD | -12.59% |
| 2020 Q1 | 151.06 Thousand CAD | 1311.15% |
| 2019 Q2 | 119.77 Thousand CAD | -30.81% |
| 2019 Q4 | 10.7 Thousand CAD | -92.09% |
| 2019 Q1 | 173.1 Thousand CAD | 0.0% |
| 2019 Q3 | 135.37 Thousand CAD | 13.02% |
| 2019 FY | 750.76 Thousand USD | -6.8% |
| 2018 FY | 805.53 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -124.524% |
| Arrayit Corporation | 6.19 Million USD | 61.997% |
| Atlantic International Corp. | 5.57 Million USD | 57.778% |
| Biocept, Inc. | 29.4 Million USD | 91.989% |
| Bioqual, Inc. | 7.44 Million USD | 68.381% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -205.03% |
| DermTech, Inc. | 104.01 Million USD | 97.736% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 98.585% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 89.589% |
| iMD Companies, Inc. | 151.8 Thousand USD | -1451.463% |
| IDenta Corp. | 662.97 Thousand USD | -255.256% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 88.359% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -5957.614% |
| InVitro International | 661.32 Thousand USD | -256.143% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 66.818% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -3952.968% |
| Medical Imaging Corp. | 1.91 Million USD | -23.173% |
| NovelStem International Corp. | 3.53 Million USD | 33.426% |
| Optigenex Inc. | 1.28 Million USD | -82.88% |
| PharmChem, Inc. | 2.93 Million USD | 19.649% |
| Proteome Sciences plc | 3.26 Million USD | 27.93% |
| Response Genetics, Inc | 25.31 Million USD | 90.698% |
| Rennova Health, Inc. | 7.67 Million USD | 69.324% |
| RushNet, Inc. | 1.78 Million USD | -31.629% |
| ScreenPro Security Inc. | 3.23 Million USD | 27.282% |
| Stella Diagnostics Inc. | 11.42 Million USD | 79.389% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 67.925% |
| Todos Medical Ltd. | 14.05 Million USD | 83.246% |